Valuation and Targets, page-333

Here we go

2020	2021	2,022	2023	2024	2025	2026	2027
	1	2	3	4	5	6	7
Revenue			6200	6200	6200	6200	6200
	450	450	450	450	450	450	450
revenue discounted @ 15% pa								sum
	382.5	325	4084	3471	2951	2508	2132	15853

It is a matter of judgement what the GP % would be. However it may be necessary to give Bene a royalty, but we could be looking at 40% after that and allowing for continuing R&D.
The other issue is at what point does the market look at revenue in the same way as the other Ozy growth stocks (APT etc) after the COVID chaos.
I am thinking the market will assess PAR on a similar basis to APT because they can see the market size.
At the very least there is an outlook potential of 700m revenue over two years from TGA starting end 2Q 2021.
40% GP of that gives what EPS? If only that GP was given 20x markup for potential, we get 280*20=$5.6B which i think comes to
>$20 share. IMO only DYOR.